Both in Pharmaceuticals
DiaMedica Therapeutics vs Aclaris Therapeutics
Over the past year DMAC returned +60.5% and ACRS returned +55.9%; their daily moves had a correlation of 0.19.
DMAC +60.5% ACRS +55.9%Growth of $1, one year, split-adjusted
| Metric | DMAC | ACRS |
|---|---|---|
| Price | $10.77 | $3.68 |
| Market cap | $580.8M | $570.3M |
| Today | +7.70% | −1.60% |
| 1 month | +32.5% | −0.5% |
| 6 months | +65.2% | −23.0% |
| Year to date | +35.3% | +22.3% |
| 1 year | +58.4% | +43.8% |
| Revenue growth (YoY) | — | −8.3% |
| Gross margin | — | 86.6% |
| Net margin | — | −1320.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 69.4× |
| Net cash | $43.5M | $91.6M |
| Dividend yield | — | — |
| Volatility (60d) | 56.2% | 75.7% |
| Short % of float | 21.5% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).